384 related articles for article (PubMed ID: 33890993)
1. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
[TBL] [Abstract][Full Text] [Related]
2. Ondansetron in pregnancy and risk of adverse fetal outcomes.
Pasternak B; Svanström H; Hviid A
N Engl J Med; 2013 Feb; 368(9):814-23. PubMed ID: 23445092
[TBL] [Abstract][Full Text] [Related]
3. Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study.
Fisher A; Paterson JM; Winquist B; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Dormuth CR;
PLoS One; 2022; 17(12):e0277623. PubMed ID: 36454900
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
[TBL] [Abstract][Full Text] [Related]
5. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
[TBL] [Abstract][Full Text] [Related]
6. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.
Mølgaard-Nielsen D; Svanström H; Melbye M; Hviid A; Pasternak B
JAMA; 2016 Jan; 315(1):58-67. PubMed ID: 26746458
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
[TBL] [Abstract][Full Text] [Related]
8. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Ankarfeldt MZ; Petersen J; Andersen JT; Li H; Motsko SP; Fast T; Hede SM; Jimenez-Solem E
PLoS Med; 2021 Nov; 18(11):e1003851. PubMed ID: 34807906
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron use in early pregnancy and the risk of miscarriage.
Suarez EA; Boggess K; Engel SM; Stürmer T; Lund JL; Jonsson Funk M
Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):103-113. PubMed ID: 33000871
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous Abortion.
Andersson NW; Thomsen SF; Andersen JT
JAMA Dermatol; 2020 Apr; 156(4):375-383. PubMed ID: 32129793
[TBL] [Abstract][Full Text] [Related]
11. Off-label use of ondansetron in pregnancy in Western Australia.
Colvin L; Gill AW; Slack-Smith L; Stanley FJ; Bower C
Biomed Res Int; 2013; 2013():909860. PubMed ID: 24396830
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
Fejzo MS; MacGibbon KW; Mullin PM
Reprod Toxicol; 2016 Jul; 62():87-91. PubMed ID: 27151373
[TBL] [Abstract][Full Text] [Related]
13. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
Kharbanda EO; Vazquez-Benitez G; DeSilva MB; Naleway AL; Klein NP; Hechter RC; Glanz JM; Donahue JG; Jackson LA; Sheth SS; Greenberg V; Panagiotakopoulos L; Mba-Jonas A; Lipkind HS
JAMA Netw Open; 2021 Apr; 4(4):e214340. PubMed ID: 33818618
[TBL] [Abstract][Full Text] [Related]
14. First trimester ondansetron exposure and risk of structural birth defects.
Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study.
Ostenfeld A; Petersen TS; Pedersen LH; Westergaard HB; Løkkegaard ECL; Andersen JT
Acta Psychiatr Scand; 2022 Jun; 145(6):557-567. PubMed ID: 35320582
[TBL] [Abstract][Full Text] [Related]
16. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.
Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Sheth SS; Zhu J; Naleway AL; Klein NP; Hechter R; Daley MF; Donahue JG; Jackson ML; Kawai AT; Sukumaran L; Nordin JD
Obstet Gynecol; 2018 Jul; 132(1):35-44. PubMed ID: 29889760
[TBL] [Abstract][Full Text] [Related]
17. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
[TBL] [Abstract][Full Text] [Related]
18. Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study.
Bech BH; Kjaersgaard MI; Pedersen HS; Howards PP; Sørensen MJ; Olsen J; Parner ET; Pedersen LH; Vestergaard M; Christensen J
BMJ; 2014 Aug; 349():g5159. PubMed ID: 25150301
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
Mayhall EA; Gray R; Lopes V; Matteson KA
Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
[TBL] [Abstract][Full Text] [Related]
20. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.
Scheller NM; Pasternak B; Mølgaard-Nielsen D; Svanström H; Hviid A
N Engl J Med; 2017 Mar; 376(13):1223-1233. PubMed ID: 28355499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
